HTL Biotechnology
Emilie Vanderborght is an experienced quality management professional with a robust background in the biotechnology and pharmaceutical sectors. Currently serving as the Responsable Contrôle Qualité produit at HTL Biotechnology since April 2023, Emilie oversees a team of technicians and leads a project for implementing a Laboratory Information Management System (LIMS). Previous roles include Responsable contrôle qualité at Pharma & Beauty Group and Ingénieur Qualité & Metrologie at C4Diagnostics. At Codif International, Emilie managed a team of 13 across five laboratories, ensuring compliance and quality across various products. Emilie's career began with a focus on cosmetic and detergent quality control and includes significant contributions to forensic research. Emilie holds a Master 2 (M2) degree in Chemistry from Aix-Marseille University.
This person is not in any offices
HTL Biotechnology
HTL is the world leader in the development and production of pharmaceutical grade biopolymers used to develop life-changing treatments for millions of patients. A pioneer in the bioproduction of hyaluronic acid, HTL has developed and refined for over 30 years its innovative functional biopolymer platform that has enabled it to produce "customised" pharmaceutical grade products for the leaders of the pharmaceutical and medical devices sectors in therapeutic areas such as ophthalmology, dermatology, medical aesthetics, rheumatology and urology Thanks to its dedicated R&D team, its partnerships and its incubator, HTL is now driving innovation in the biopolymer sector. Its R&D strategy aims to address unmet medical needs by creating new types of biopolymers, modifying their physico-chemical properties, and exploring new medical applications in cutting-edge areas such as bioprinting and drug delivery. very.